HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
336.24
+11.62 (3.58%)
Apr 23, 2025, 4:00 PM EDT - Market closed

HCA Healthcare Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 376.2, with a low estimate of 320 and a high estimate of 440. The average target predicts an increase of 11.88% from the current stock price of 336.24.

Analyst Consensus: Buy
Target Low Average Median High
Price $320 $376.2 $375 $440
Change -4.83% +11.88% +11.53% +30.86%

Analyst Ratings

The average analyst rating for HCA Healthcare stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 334444
Buy 667776
Hold 554446
Sell 111111
Strong Sell 000000
Total 151516161617

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Baird
Baird
Hold
Downgrades
$396$336
Hold Downgrades $396$336 -0.07% Apr 15, 2025
Guggenheim
Guggenheim
Hold
Initiates
n/a
Hold Initiates n/a n/a Apr 9, 2025
RBC Capital
RBC Capital
Buy
Maintains
$405$384
Buy Maintains $405$384 +14.20% Jan 27, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$380$370
Strong Buy Maintains $380$370 +10.04% Jan 27, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$405
Buy Reiterates $405 +20.45% Jan 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
75.40B
from 70.60B
Increased by 6.80%
Revenue Next Year
79.29B
from 75.40B
Increased by 5.16%
EPS This Year
25.17
from 22.00
Increased by 14.39%
EPS Next Year
28.34
from 25.17
Increased by 12.62%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
51.53B58.75B60.23B64.97B70.60B75.40B79.29B83.47B
Revenue Growth
0.38%14.01%2.52%7.86%8.67%6.80%5.16%5.27%
EPS
10.9321.1619.1518.9722.0025.1728.3431.66
EPS Growth
8.54%93.60%-9.50%-0.94%15.97%14.39%12.62%11.70%
Forward PE
-----13.3611.8610.62
No. Analysts
-----262512
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 79.6B 85.3B 90.2B
Avg 75.4B 79.3B 83.5B
Low 72.3B 75.5B 78.8B

Revenue Growth

Revenue Growth 20252026202720282029
High
12.8%
13.1%
13.7%
Avg
6.8%
5.2%
5.3%
Low
2.4%
0.1%
-0.6%

EPS Forecast

EPS 20252026202720282029
High 26.70 30.84 34.14
Avg 25.17 28.34 31.66
Low 23.90 26.47 29.70

EPS Growth

EPS Growth 20252026202720282029
High
21.4%
22.5%
20.4%
Avg
14.4%
12.6%
11.7%
Low
8.6%
5.2%
4.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.